» Authors » Shao-Liang Chen

Shao-Liang Chen

Explore the profile of Shao-Liang Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 284
Citations 3709
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Kong X, Zhang J, Gao X, Wang Z, Ye P, Zhang J, et al.
Catheter Cardiovasc Interv . 2024 Aug; 104(6):1275-1280. PMID: 39189047
Aims: To evaluate the safety and efficacy of transcatheter aortic valve implantation (TAVI) for the treatment of aortic regurgitation (AR). Methods: From September 2019 to February 2022, 62 patients who...
12.
Wu Z, Kan J, Ye F, You W, Wu X, Tian N, et al.
Am Heart J . 2024 Jun; 277:58-65. PMID: 38942221
Background: It is currently uncertain whether the combination of a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor and high-intensity statin treatment can effectively reduce cardiovascular events in patients with acute...
13.
Zhang J, Hwang D, Yang S, Hu X, Lee J, Nam C, et al.
JAMA Netw Open . 2024 Jun; 7(6):e2418072. PMID: 38904958
Importance: The associations between angiographic findings and post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) and their clinical relevance according to residual functional disease burden have not been thoroughly investigated....
14.
Gao X, Ge Z, Kong X, Chen X, Han L, Qian X, et al.
JACC Cardiovasc Interv . 2024 Jun; 17(13):1519-1528. PMID: 38842991
Background: Drug-coated balloon (DCB) angioplasty seems a safe and effective option for specific de novo coronary lesions. However, the beneficial effect of intravascular ultrasound (IVUS)-guided DCB angioplasty in de novo...
15.
Wu X, Wang X, Zhang L, Pan Z, Chen F, Chen S, et al.
ESC Heart Fail . 2024 May; 11(5):2889-2900. PMID: 38783684
Aims: A recent guideline presented by the ESC Congress in 2022 had indicated a novel therapy targeted at pulmonary artery hypertension, known as pulmonary artery denervation (PADN), which get inspired...
16.
Li X, Ge Z, Kan J, Anjum M, Xie P, Chen X, et al.
Lancet . 2024 Apr; 403(10439):1855-1865. PMID: 38604212
Background: Intravascular ultrasound-guided percutaneous coronary intervention has been shown to result in superior clinical outcomes compared with angiography-guided percutaneous coronary intervention. However, insufficient data are available concerning the advantages of...
17.
Ge Z, Kan J, Gao X, Raza A, Zhang J, Mohydin B, et al.
Lancet . 2024 Apr; 403(10439):1866-1878. PMID: 38599220
Background: Following percutaneous coronary intervention with stent placement to treat acute coronary syndromes, international clinical guidelines generally recommend dual antiplatelet therapy with aspirin plus a P2Y receptor inhibitor for 12...
18.
Choi K, Kwon W, Shin D, Lee S, Hwang D, Zhang J, et al.
JACC Asia . 2024 Mar; 4(3):229-240. PMID: 38463680
Background: Both left ventricular systolic function and fractional flow reserve (FFR) are prognostic factors after percutaneous coronary intervention (PCI). However, how these prognostic factors are inter-related in risk stratification of...
19.
Zhang J, Kong X, Gao X, Chen J, Chen X, Li B, et al.
Am Heart J . 2024 Feb; 271:76-83. PMID: 38412895
Background: Previous studies primarily demonstrated that transfemoral transcatheter aortic valve replacement (TAVR) with self-expanding valve appeared to be a safe and feasible treatment for patients with pure native aortic regurgitation...
20.
Shi Y, Wu L, Feng X, Kan J, Kong C, Ling Z, et al.
Circ J . 2024 Jan; 88(3):417-424. PMID: 38267051
Background: This study aimed to investigate the association between estimated pulse wave velocity (ePWV) and mortality outcomes among individuals with hypertension. Methods and results: Based on the National Health and...